Genetically engineered mice with targeted disruption of the neuronal nitric oxide synthase (nNOS) gene established the inhibitory role of nitric oxide (NO) in male impulsive aggressive behavior. This was later confirmed by using selective nNOS inhibitors in male wild-type mice. The molecular mechanisms accounting for the aggressive behavior caused by the lack of neuronally derived NO is not known. Recent studies suggest that central serotonergic neuronal circuits and particularly 5-HT1A and 5-HT1B receptors play a prominent role in the regulation of aggression. Accordingly, we investigated whether the aggressiveness caused by the lack of nNOS might be because of alterations in serotonergic function. We now demonstrate that the excessive aggressiveness and impulsiveness of nNOS knockout mice is caused by selective decrements in serotonin (5-HT) turnover and deficient 5-HT1A and 5-HT1B receptor function in brain regions regulating emotion. These results indicate an important role for NO in normal brain 5-HT function and may have significant implications for the treatment of psychiatric disorders characterized by aggressiveness and impulsivity.
Genetically engineered mice with targeted disruption of the neuronal nitric oxide synthase (nNOS) gene established the inhibitory role of nitric oxide (NO) in male impulsive aggressive behavior. This was later confirmed by using selective nNOS inhibitors in male wild-type mice. The molecular mechanisms accounting for the aggressive behavior caused by the lack of neuronally derived NO is not known. Recent studies suggest that central serotonergic neuronal circuits and particularly 5-HT1A and 5-HT1B receptors play a prominent role in the regulation of aggression. Accordingly, we investigated whether the aggressiveness caused by the lack of nNOS might be because of alterations in serotonergic function. We now demonstrate that the excessive aggressiveness and impulsiveness of nNOS knockout mice is caused by selective decrements in serotonin (5-HT) turnover and deficient 5-HT1A and 5-HT1B receptor function in brain regions regulating emotion. These results indicate an important role for NO in normal brain 5-HT function and may have significant implications for the treatment of psychiatric disorders characterized by aggressiveness and impulsivity.
T he gene encoding neuronal nitric oxide synthase (nNOS) was disrupted and inactivated by homologous recombination to clarify the functional role of nitric oxide (NO) as a messenger molecule in the nervous system (1) . Mice lacking the gene for nNOS (nNOS Ϫ/Ϫ ) exhibit a variety of abnormalities including enlargement of the stomach (1), hypertrophied urinary bladders (2) , reduced parasympathetic tone (3) , and nocturnal motor deficits (4) . In addition, male nNOS Ϫ/Ϫ mice display dramatic increases in aggressive and sexual behavior (5) . Pharmacological treatment of male wild-type (WT) mice with selective nNOS inhibitor also evokes an increase in impulsive aggressive behavior to the levels displayed by nNOS Ϫ/Ϫ mice (6) , indicating that the aggressive behavior is caused by loss of neuronally derived NO and not developmental abnormalities. nNOS is enriched throughout the limbic system (7, 8) , an area important in emotional and agonistic behaviors and thus nNOS-derived NO is appropriately positioned to play a prominent role in regulating impulsive and aggressive behavior. Despite the evidence which implicates neuron-derived NO in the modulation of aggressive behavior, the molecular mechanisms by which NO regulate aggression are not known. Plasma androgen concentrations can affect the display of aggressive behavior in male mice, but testosterone concentrations in nNOS Ϫ/Ϫ and WT mice are similar (9) .
Previous studies of the brain mechanisms underlying aggression reveal that central serotonergic neuronal circuits are prominent in the regulation of aggression. For instance, a negative correlation exists between serotonin (5-hydroxytryptamine; 5-HT) metabolites and impulsive aggressiveness in humans (10) (11) (12) and rodents (13, 14) . Pharmacological manipulations that increase 5-HT neurotransmission decrease the severity of aggressiveness in humans (15) and reduce aggression in animal models (16, 17) . Studies with selective 5-HT receptor agonists and genetically engineered mice strongly implicate the 5-HT 1A , 5-HT 1B , or both receptor subtypes in aggression (18) (19) (20) (21) (22) . Here we investigate the relationship of 5-HT and NO in aggression and report that the excessive aggressiveness and impulsivity of male nNOS Ϫ/Ϫ mice is caused by selective decrements in 5-HT turnover and deficient 5-HT 1A and 5-HT 1B receptor function in brain regions regulating emotion.
Materials and Methods
Animals. Adult (3-to 5-month-old) male nNOS Ϫ/Ϫ and WT C57BL͞6J mice from a breeding colony established at The Johns Hopkins University by using animals previously produced by homologous recombination (1) were singly housed in polycarbonate cages (28 ϫ 17 ϫ 12 cm) with ad libitum access to food (Prolab 2000; Agway, Syracuse, NY) and tap water. The nNOS Ϫ/Ϫ mice have been backcrossed to the C57BL͞6J mice at least eight generations. Male young adult CD-1 mice (Charles River Breeding Laboratories) socially housed in groups of five per cage were used as intruders. All animals were maintained on a light͞dark 16:8 photoperiod (lights on 700 h) with an ambient temperature of 22 Ϯ 2°C and relative humidity of 50 Ϯ 5% throughout the duration of the study. The behavioral tests as well as the decapitations were performed at the same period of the light cycle (1300-1800 h). and norepinephrine bitartrate were purchased from Research Biochemicals.
Aggression Test (Resident-Intruder Paradigm). The home cages of resident mice (nNOS Ϫ/Ϫ or WT) were not changed during the last week of the isolation period of 3-4 weeks. A young adult stimulus male mouse (intruder) was introduced into the home cage of the resident, and the latency to first attack bite, the total number of attack bites, and the total duration of attack episodes (bursts of bites, sideways threats, and rough grooming) initiated by the resident male was recorded for 900 s in the first confrontation. Each resident mouse was used only once and the intruder mice were used only once a day. The test was videotaped overhead and scored by two observers unaware of either the genotype or experimental treatment. For the 5-HT 1A and 5-HT 1B agonist treatments, other WT or nNOS Ϫ/Ϫ isolated mice (residents) were previously exposed to an intruder each 3 days in a total of four confrontations of 15 min each. Previous studies have shown that the high variability of the initial confrontation is reduced after some encounters (23) . Experimental tests were conducted at 3-day intervals with counterbalanced sequence of doses. and WT mice were decapitated in random order and several brain structures were dissected as follows: hypothalamus, cerebellum, midbrain, hippocampus, amygdala, and cerebral cortex. They were immediately frozen in dry ice, and stored at Ϫ70°C until use. The tissues were thawed, weighed, and ultrasonically homogenized in 0.1 M cold perchloric acid͞0.01% ascorbic acid and known amounts of 3,4-dihydroxybenzylamine hydrobromide as internal control. After centrifugation at 16,000 ϫ g for 20 min at 4°C, the supernatants were filtered (0.45 m) and injected (20 l) onto the HPLC column [BAS (West Lafayette, IN) Biophase ODS 5 m, 250 ϫ 4.6 mm]. The mobile phase consisted of filtered 150 mM monochloroacetic acid͞200 mg/liter sodium octyl sulfate͞0.1 mM EDTA͞4% acetonitrile͞2.5% tetrahydrofuran (pH 3.0) and the flow rate was set at 1.5 ml͞min. 5-HT, 5-HIAA, norepinephrine bitartrate, 3-hydroxytyramine hydrochloride, 4-hydroxy-3-methoxyphenylacetic acid, and 3,4-dihydroxyphenylacetic acid were electrochemically detected by using a working potential of 800 mV (BAS LC-4C amperometric detector with a glassy carbon electrode coupled to a Dynamax SD-200 system). The concentrations were calculated by reference to standard curves run daily.
5-HT Immunocytochemistry. Nine mice (four WT and five nNOS Ϫ/Ϫ ) were anesthetized with 400 mg͞kg chloral hydrate and transcardiacally perfused with cold PBS (pH 7.4) solution followed by cold 4% paraformaldehyde. The brains were removed from the skull and postfixed for 4 h in the same cold fixative, and cryoprotected for 1 day in cold 20% sucrose in PBS and 1 day in cold 30% sucrose in PBS. The brains were frozen and cut at 30 m (sagitally or coronally) on a freezing sliding microtome. The sections were incubated for 1 h in blocking solution (6% normal goat serum͞0.2% Triton X-100͞5% dry nonfat milk) and for 2 days with rabbit anti-5-HT antibody (1:10,000; Incstar, Stillwater, MN) in a cold room on a rotator. After washes in PBS, the sections were incubated for 40 min in biotinylated goat anti-rabbit secondary antibody (1:200), exposed to an avidin-biotin complex (Vector IgG Elite Kit), and processed in diaminobenzidine as a chromogen. The sections were mounted on subbed slides, allowed to dry overnight, and amplified by silver staining.
Pharmacological Manipulations of the 5-HT Turnover. Seventy mice (35 each genotype) were used for the 5-HT precursor studies. 5-HTP was administered i.p. in doses of 50 and 100 mg͞kg 30 min before the tests. Fifty-two mice (26 each genotype) were used for the inhibition of the 5-HT synthesis. pCPA was injected i.p. in a single dose of 300 mg͞kg 72 h before the aggression tests (1 ϫ 300) or a regimen of daily injections of 300 mg͞kg 24, 48, and 72 h before testing (3 ϫ 300). The time point was selected based on previous studies that documented the peak of 5-HT decrease is obtained at 72 h after pCPA injection (24). To ascertain whether nNOS Ϫ/Ϫ mice have altered 5-HT metabolism, we compared 5-HT and its metabolite 5-HIAA levels in nNOS Ϫ/Ϫ and WT mice. Total tissue content of 5-HT is increased in the cerebral cortex (20.6%), hypothalamus (13.0%), hippocampus (14.2%), midbrain (16.1%), and cerebellum (40.4%) (P Ͻ 0.05 in each case) with no concomitant changes in 5-HIAA (P Ͼ 0.05) in nNOS Ϫ/Ϫ mice. The 5-HIAA͞5-HT ratio, an indicator of 5-HT turnover, is reduced in the cortex (18.1%), hypothalamus (18%), midbrain (16.4%), and cerebellum (30.4%) of nNOS Ϫ/Ϫ mice (P Ͻ 0.01 for cerebellum and P Ͻ 0.05 for other areas; Fig. 1 ). Norepinephrine, 3-hydroxytyramine, 3,4-dihydroxyphenylacetic acid, and 4-hydroxy-3-methoxyphenylacetic acid are not altered in most brain areas studied, including cortex, hypothalamus, hippocampus, and midbrain (P Ͼ 0.05; data not shown). Thus, it is unlikely that alterations in monoamine oxidase account for the abnormalities in 5-HT in the nNOS Ϫ/Ϫ mice. mice treated with saline, P Ͻ 0.01 and P Ͻ 0.05; Fig. 2 A and B) . 5-HTP treatment reduces the number and duration, and increases the latency of attacks (P Ͻ 0.05; Fig. 2 A and B (Fig. 2D) , and 5-HT turnover are dramatically increased in the cerebral cortex, hypothalamus, hippocampus, amygdala, midbrain, and cerebellum of both genotypes. Therefore, the aggressive phenotype of nNOS Ϫ/Ϫ mice can be eliminated in a dose-dependent manner by augmenting 5-HT neurotransmission in the brain.
Decrements in 5-HT Neurotransmission Enhances Aggressive Behavior.
We next evaluated the effects of reducing 5-HT levels per turnover with pCPA, an inhibitor of the 5-HT-synthesizing enzyme tryptophan hydroxylase, on aggressive behavior in nNOS Ϫ/Ϫ and WT mice. A single i.p. administration of 300 mg͞kg pCPA 72 h before behavioral testing fails to induce any alterations in aggression (P Ͼ 0.05; Fig. 3 A and B) . However, this regimen produces only a partial reduction in 5-HT levels and turnover in some brain areas (Fig. 3D) . A sequential regimen involving three daily injections of 300 mg͞kg pCPA 72, 48, and 24 h before testing leads to a profound reduction of 5-HT levels and turnover in all brain areas analyzed (Fig. 3E) . Decrements in 5-HT neurotransmission are associated with an increase in number of attacks in WT but not in nNOS Ϫ/Ϫ mice (P Ͻ 0.05 and P Ͼ 0.05, respectively; Fig. 3A) . The latency to first bite, an index of impulsivity, is reduced in WT mice with the highest dose of pCPA (P Ͻ 0.01), but latency is not reduced in nNOS Ϫ/Ϫ animals (P Ͼ 0.05; Fig. 3B ). Thus, the effective reduction of 5-HT neurotransmission over a period of 3 days is able to induce aggressiveness in WT animals comparable to mice lacking nNOS. Fig. 2C ). The repeated pCPA regimen does not change locomotor activity within each genotype (P Ͼ 0.05; Fig. 3C ), but the total locomotion of nNOS Ϫ/Ϫ mice is reduced compared with WT (P Ͻ 0.05; Fig.  3C ), despite the marked persistent increase in aggressiveness (P Ͻ 0.05; Fig. 3A) . Taken together, these results suggest the alterations in aggressive behavior elicited by 5-HTP and pCPA are not associated with alterations in motor function.
Alterations in Aggressive Behavior
Forebrain 5-HT Immunoreactivity Is Unaltered in nNOS ؊/؊ Mice. Mice lacking one copy of the brain-derived neurotrophic factor gene are aggressive and show age-related alterations in the disposition and density of serotonergic fibers and terminals (25) . Accordingly, we examined the distribution and density of 5-HT terminals in nNOS Ϫ/Ϫ mice by immunocytochemistry (Fig. 4) . There is no significant alteration in the density and pattern of 5-HT terminals in the nNOS (19, 21, 26, 27) , and mice lacking the 5-HT 1B receptor are aggressive (22) . To ascertain whether alterations in 5-HT 1A and 5-HT 1B receptor function could contribute to the aggressive behavior of nNOS Ϫ/Ϫ mice, we examined the effects of selective 5-HT 1A, and 5-HT 1B agonists on the behavior of WT and nNOS Ϫ/Ϫ mice (Fig. 5) . To compare the effects of the 5-HT agonists in WT vs. nNOS Ϫ/Ϫ mice, the level of aggressiveness in WT mice must be experimentally increased. Previous studies indicate that repeated exposures to the resident-intruder paradigm increase aggressive behavior (23) . Accordingly, both WT and nNOS Ϫ/Ϫ mice were repeatedly exposed to the resident-intruder paradigm for 15 min every 3 days for a total of four exposures, which significantly increases the aggressive behavior of WT mice to levels near to the level observed in nNOS Ϫ/Ϫ mice, but does not change the aggressive behavior of the nNOS Ϫ/Ϫ mice (data not shown). The 5-HT 1A agonist, 8-OH-DPAT, and the 5-HT 1B agonist, CP-94,253, significantly decrease aggressive behavior in both WT and nNOS Ϫ/Ϫ mice by reducing the number and duration of attacks and increasing the latency to first attack (Fig. 5 A, C, B, and D, respectively) . Although both 5-HT agonists reduce aggressive behavior in both WT and nNOS Ϫ/Ϫ mice, significantly higher concentrations of both agonists are required to reduce the aggressive behavior in the nNOS Ϫ/Ϫ mice. The ED 50 for the antiaggressive effect of 8-OH-DPAT and CP-94,253 for nNOS Ϫ/Ϫ mice is 4-and 1.8-fold higher, respectively, than the ED 50 for WT mice in number of attacks (P Ͻ 0.01 and P Ͻ 0.05, respectively; Fig. 5 A and C) . We controlled for potential changes in motoric function by assessing behavior in the open-field arena and rotarod in response to 0.1 mg͞kg 8-OH-DPAT and 10.0 mg͞kg CP-94,253-i.e., the highest doses used in the aggression tests. There is no significant effect of these compounds in locomotion, exploratory behavior, or motor coordination (P Ͼ 0.05; data not shown). Thus, the reduced sensitivity to the antiaggressive effects of 5-HT 1A and 5-HT 1B receptor agonists are likely to represent functional alterations of these receptors in the brains of nNOS Ϫ/Ϫ mice that lead to the dramatically aggressive phenotype.
Discussion
Here we report that the intense aggression observed in mice lacking neuronal-derived NO is caused by alterations in serotonergic signaling. Specifically, we note that 5-HT turnover in several brain regions is significantly reduced in male nNOS Ϫ/Ϫ mice with no detectable modifications in the dopamine or norepinephrine systems. Pharmacological treatment that increases central 5-HT neurotransmission decrease, in a dosedependent manner, aggressive behavior in nNOS Ϫ/Ϫ mice. We can induce similar high levels of aggression after reducing 5-HT turnover in WT mice. Moreover, the alterations in 5-HT turnover do not reflect changes in the disposition and density of serotonergic fibers and terminals. Importantly, there is a hypofunction in the 5-HT 1A and 5-HT 1B receptors in nNOS Ϫ/Ϫ mice.
Taken together, our results suggest that neuronal-derived NO is essential to the normal function of the central 5-HT system.
The linkage of NO with 5-HT function in aggression-related brain areas reveals novel molecular insights into the mechanisms of aggression. NO seems to play an important modulatory effect in the serotonergic system, especially in the 5-HT 1A and͞or 5-HT 1B postsynaptic receptor function and the absence of NO leads to an increase in impulsive and aggressive behavior through alterations in serotonergic circuits. Other causes of aggressive and impulsive behavior may also lead to selective decrements in serotonergic function, and thus this may represent a final or major common pathway for aggressiveness and impulsivity. Although dysfunction in central 5-HT neurons may represent a final common pathway for the elaboration of aggressiveness and impulsivity, our data suggest a specific upstream mechanism involving nNOS͞NO. These observations link two major pathways of neuronal signaling in one pathophysiological cascade and have significant implications for the treatment of psychiatric disorders characterized by aggressiveness and impulsivity.
